NIH-funded research R01 grant

Investigating how age affects the effectiveness of enoxaparin in preventing blood clots in critically ill children

Official title: Age-dependent heterogeneity in the efficacy of prophylaxis with enoxaparin against catheter-associated thrombosis in critically ill children

Funded at Yale University · NIH-10893387 · Data updated 2026-11-12

This study is looking at how well enoxaparin, a blood thinner, works for critically ill kids of different ages who are at risk for blood clots, to find the best ways to keep them safe and healthy.

More Thrombosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 10, 2021
Project endAugust 31, 2026
Funding year2024
Award (this year)$689,349
NIH project number5R01HD106326-04
Project IDNIH-10893387 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are critically ill children, particularly those under 21 years old, who require central venous catheters.

Less likely to help

Patients who are not critically ill or do not require central venous catheters may not benefit from this research.

What this research studies

This research focuses on understanding how the effectiveness of enoxaparin, a common anticoagulant, varies with age in critically ill children at risk for catheter-associated blood clots. The study will involve administering enoxaparin to children and comparing the outcomes to those receiving standard care. By analyzing data from previous clinical trials, the researchers aim to identify the most effective age groups for this treatment. This could lead to tailored prophylactic strategies that better protect young patients from serious complications.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of catheter-associated blood clots in critically ill children, improving their overall health outcomes.

How similar studies have gone: Previous studies have shown promising results with similar approaches in adult populations, but this specific age-dependent analysis in children is novel.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Faustino, Edward Vincent — Yale University
  • Study coordinator: Faustino, Edward Vincent

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.